
William Y. Lee
Examiner (ID: 19406)
| Most Active Art Unit | 1629 |
| Art Unit(s) | 1629, 1623 |
| Total Applications | 852 |
| Issued Applications | 350 |
| Pending Applications | 117 |
| Abandoned Applications | 407 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17829954
[patent_doc_number] => 20220267258
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => ROBENIDINE ANALOGS AS POTENT ANTIMALARIALS AGAINST DRUG-RESISTANT PLASMODIUM FALCIPARUM
[patent_app_type] => utility
[patent_app_number] => 17/592366
[patent_app_country] => US
[patent_app_date] => 2022-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16389
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17592366
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/592366 | ROBENIDINE ANALOGS AS POTENT ANTIMALARIALS AGAINST DRUG-RESISTANT PLASMODIUM FALCIPARUM | Feb 2, 2022 | Abandoned |
Array
(
[id] => 17774819
[patent_doc_number] => 20220241168
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => COMPOSITION FOR STIMULATING BETA-ENDORPHIN PRODUCTION COMPRISING SANSHOOL
[patent_app_type] => utility
[patent_app_number] => 17/589202
[patent_app_country] => US
[patent_app_date] => 2022-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5301
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17589202
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/589202 | COMPOSITION FOR STIMULATING BETA-ENDORPHIN PRODUCTION COMPRISING SANSHOOL | Jan 30, 2022 | Abandoned |
Array
(
[id] => 17593427
[patent_doc_number] => 20220143000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => TREATMENT OF AUTOIMMUNE DISEASES WITH COMBINATIONS OF RXR AGONISTS AND THYROID HORMONES
[patent_app_type] => utility
[patent_app_number] => 17/585349
[patent_app_country] => US
[patent_app_date] => 2022-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20414
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17585349
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/585349 | Treatment of autoimmune diseases with combinations of RXR agonists and thyroid hormones | Jan 25, 2022 | Issued |
Array
(
[id] => 20479319
[patent_doc_number] => 12527782
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-20
[patent_title] => Use of hexokinase 2/mitochondria-detaching compounds for treating hexokinase-2 (HK2)-expressing cancers
[patent_app_type] => utility
[patent_app_number] => 17/583238
[patent_app_country] => US
[patent_app_date] => 2022-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 26
[patent_no_of_words] => 22753
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 228
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17583238
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/583238 | Use of hexokinase 2/mitochondria-detaching compounds for treating hexokinase-2 (HK2)-expressing cancers | Jan 24, 2022 | Issued |
Array
(
[id] => 20714124
[patent_doc_number] => 12629348
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-05-19
[patent_title] => Method and composition for treating osteoarthritis
[patent_app_type] => utility
[patent_app_number] => 17/582595
[patent_app_country] => US
[patent_app_date] => 2022-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 1559
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17582595
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/582595 | METHOD AND COMPOSITION FOR TREATING OSTEOARTHRITIS | Jan 23, 2022 | Issued |
Array
(
[id] => 19367416
[patent_doc_number] => 12059477
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-13
[patent_title] => Nanomaterials
[patent_app_type] => utility
[patent_app_number] => 17/579115
[patent_app_country] => US
[patent_app_date] => 2022-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 59387
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 479
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17579115
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/579115 | Nanomaterials | Jan 18, 2022 | Issued |
Array
(
[id] => 17576887
[patent_doc_number] => 20220133742
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => METHODS OF TREATING CONGENITAL ADRENAL HYPERPLASIA
[patent_app_type] => utility
[patent_app_number] => 17/578149
[patent_app_country] => US
[patent_app_date] => 2022-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19925
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -102
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17578149
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/578149 | METHODS OF TREATING CONGENITAL ADRENAL HYPERPLASIA | Jan 17, 2022 | Pending |
Array
(
[id] => 17776527
[patent_doc_number] => 20220242876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => HETEROCYCLIC COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/569749
[patent_app_country] => US
[patent_app_date] => 2022-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35180
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17569749
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/569749 | HETEROCYCLIC COMPOUNDS | Jan 5, 2022 | Pending |
Array
(
[id] => 17688232
[patent_doc_number] => 20220195524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => METHODS AND COMPOSITIONS FOR DIAGNOSIS AND MANAGEMENT OF NEURODEGERATIVE DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/568617
[patent_app_country] => US
[patent_app_date] => 2022-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34994
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17568617
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/568617 | Methods and compositions for diagnosis and management of neurodegenerative diseases | Jan 3, 2022 | Issued |
Array
(
[id] => 17671048
[patent_doc_number] => 20220184215
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => STABLE CANNABINOID FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/559155
[patent_app_country] => US
[patent_app_date] => 2021-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13816
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17559155
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/559155 | STABLE CANNABINOID FORMULATIONS | Dec 21, 2021 | Pending |
Array
(
[id] => 18034576
[patent_doc_number] => 20220378791
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => JAK1 INHIBITORS FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROMES
[patent_app_type] => utility
[patent_app_number] => 17/556374
[patent_app_country] => US
[patent_app_date] => 2021-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19329
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17556374
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/556374 | JAK1 INHIBITORS FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROMES | Dec 19, 2021 | Pending |
Array
(
[id] => 18921295
[patent_doc_number] => 20240024299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => USE OF DRUGS THAT STIFFEN MATURE GAMETOCYTES FOR BLOCKING TRANSMISSION OF PLASMODIUM PARASITES
[patent_app_type] => utility
[patent_app_number] => 18/257438
[patent_app_country] => US
[patent_app_date] => 2021-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3609
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18257438
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/257438 | USE OF DRUGS THAT STIFFEN MATURE GAMETOCYTES FOR BLOCKING TRANSMISSION OF PLASMODIUM PARASITES | Dec 12, 2021 | Pending |
Array
(
[id] => 17482028
[patent_doc_number] => 20220089532
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => BENZENE DERIVATIVE
[patent_app_type] => utility
[patent_app_number] => 17/544616
[patent_app_country] => US
[patent_app_date] => 2021-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34827
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17544616
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/544616 | Benzene derivative | Dec 6, 2021 | Issued |
Array
(
[id] => 18251537
[patent_doc_number] => 20230078576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => COMPOUNDS AND THEIR USE
[patent_app_type] => utility
[patent_app_number] => 17/457953
[patent_app_country] => US
[patent_app_date] => 2021-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 102372
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17457953
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/457953 | Compounds and their use | Dec 6, 2021 | Issued |
Array
(
[id] => 19402129
[patent_doc_number] => 20240285640
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => COMBINATION THERAPY FOR TREATING PIK3CA-MUTATED CANCER
[patent_app_type] => utility
[patent_app_number] => 18/039282
[patent_app_country] => US
[patent_app_date] => 2021-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8065
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18039282
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/039282 | COMBINATION THERAPY FOR TREATING PIK3CA-MUTATED CANCER | Nov 29, 2021 | Pending |
Array
(
[id] => 17748133
[patent_doc_number] => 20220226336
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => COMBINATION THERAPY FOR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 17/533674
[patent_app_country] => US
[patent_app_date] => 2021-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33407
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17533674
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/533674 | COMBINATION THERAPY FOR TREATING CANCER | Nov 22, 2021 | Abandoned |
Array
(
[id] => 17944248
[patent_doc_number] => 20220331265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => COMBINATIONS OF LSD1 INHIBITORS FOR THE TREATMENT OF HEMATOLOGICAL MALIGNANCIES
[patent_app_type] => utility
[patent_app_number] => 17/531370
[patent_app_country] => US
[patent_app_date] => 2021-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15948
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17531370
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/531370 | COMBINATIONS OF LSD1 INHIBITORS FOR THE TREATMENT OF HEMATOLOGICAL MALIGNANCIES | Nov 18, 2021 | Abandoned |
Array
(
[id] => 18901322
[patent_doc_number] => 20240016807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => COMBINATION THERAPY FOR THE TREATMENT OF A LIVER DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/037123
[patent_app_country] => US
[patent_app_date] => 2021-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3325
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18037123
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/037123 | COMBINATION THERAPY FOR THE TREATMENT OF A LIVER DISEASE | Nov 15, 2021 | Pending |
Array
(
[id] => 17896924
[patent_doc_number] => 20220306586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => CANNABINOID RECEPTOR MODULATORS
[patent_app_type] => utility
[patent_app_number] => 17/520952
[patent_app_country] => US
[patent_app_date] => 2021-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 82522
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17520952
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/520952 | CANNABINOID RECEPTOR MODULATORS | Nov 7, 2021 | Abandoned |
Array
(
[id] => 17441802
[patent_doc_number] => 20220062307
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => METHODS AND MATERIALS FOR TREATING CALCIFIC AORTIC VALVE STENOSIS
[patent_app_type] => utility
[patent_app_number] => 17/521453
[patent_app_country] => US
[patent_app_date] => 2021-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5199
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17521453
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/521453 | METHODS AND MATERIALS FOR TREATING CALCIFIC AORTIC VALVE STENOSIS | Nov 7, 2021 | Abandoned |